| scholarly article | Q13442814 |
| P50 | author | James Wilson | Q16947166 |
| Alison Crawford | Q57286336 | ||
| Lili Wang | Q64356065 | ||
| E. John Wherry | Q88954779 | ||
| P2093 | author name string | Peter Bell | |
| Jianping Lin | |||
| Lauren E Mays | |||
| P2860 | cites work | Viral immune evasion due to persistence of activated T cells without effector function | Q24646943 |
| Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors | Q24673796 | ||
| Toll-like receptors: critical proteins linking innate and acquired immunity | Q29615190 | ||
| T cell exhaustion | Q29620463 | ||
| Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicity | Q33490137 | ||
| Identification of the murine AAVrh32.33 capsid-specific CD8+ T cell epitopes | Q33506448 | ||
| Induction of immune tolerance to FIX by intramuscular AAV gene transfer is independent of the activation status of dendritic cells | Q33608746 | ||
| Regulatory T cells and immune tolerance to coagulation factor IX in the context of intramuscular AAV1 gene transfer | Q33730693 | ||
| CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists. | Q33745224 | ||
| Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers | Q33782809 | ||
| CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells | Q33810726 | ||
| AAV vectors avoid inflammatory signals necessary to render transduced hepatocyte targets for destructive T cells | Q33931609 | ||
| Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells | Q34574858 | ||
| Regulatory T cells and mechanisms of immune system control | Q35852343 | ||
| Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector | Q35872651 | ||
| Muscle-directed gene therapy for hemophilia B with more efficient and less immunogenic AAV vectors. | Q36085709 | ||
| Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice | Q36144935 | ||
| Phenotypic and functional differences between human CD4+CD25+ and type 1 regulatory T cells | Q36176140 | ||
| Tr1 cells: from discovery to their clinical application. | Q36390028 | ||
| Signals required for programming effector and memory development by CD8+ T cells | Q36528952 | ||
| Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector | Q36663364 | ||
| Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness | Q36825024 | ||
| Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy | Q37066228 | ||
| Immunity to adeno-associated virus vectors in animals and humans: a continued challenge | Q37127246 | ||
| The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice | Q37286686 | ||
| Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer | Q39302902 | ||
| Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer | Q41920883 | ||
| Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver. | Q41972673 | ||
| Vaccines based on novel adeno-associated virus vectors elicit aberrant CD8+ T-cell responses in mice | Q42121728 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes | Q43205921 | ||
| Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy | Q43801966 | ||
| Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors | Q45299117 | ||
| Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins | Q45384856 | ||
| Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer | Q45874902 | ||
| An optimized protocol for detection of E. coli beta-galactosidase in lung tissue following gene transfer. | Q45884158 | ||
| PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo | Q47765780 | ||
| Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance | Q47817407 | ||
| Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver | Q48004746 | ||
| Molecular signature of CD8+ T cell exhaustion during chronic viral infection. | Q51970485 | ||
| Innate immune recognition and control of adaptive immune responses | Q77502590 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | T cell exhaustion | Q56649209 |
| P304 | page(s) | 28-41 | |
| P577 | publication date | 2013-06-19 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | AAV8 induces tolerance in murine muscle as a result of poor APC transduction, T cell exhaustion, and minimal MHCI upregulation on target cells | |
| P478 | volume | 22 |
| Q92876148 | AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer |
| Q92111662 | AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region |
| Q39409371 | Adeno-Associated Virus (AAV) as a Vector for Gene Therapy. |
| Q92234874 | Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression |
| Q57062356 | Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1 |
| Q36380744 | Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59 |
| Q39108774 | Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention |
| Q57022663 | Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration |
| Q90434853 | Cross-Presentation of Skin-Targeted Recombinant Adeno-associated Virus 2/1 Transgene Induces Potent Resident Memory CD8+ T Cell Responses |
| Q92547654 | Dual muscle-liver transduction imposes immune tolerance for muscle transgene engraftment despite preexisting immunity |
| Q43077728 | Immune tolerance in liver disease |
| Q47260510 | Inhibition of antigen presentation during AAV gene therapy using virus peptides |
| Q40117829 | Intradermal Immunization with rAAV1 Vector Induces Robust Memory CD8(+) T Cell Responses Independently of Transgene Expression in DCs. |
| Q42054746 | Mapping the structural determinants responsible for enhanced T cell activation to the immunogenic adeno-associated virus capsid from isolate rhesus 32.33. |
| Q92940638 | Muscle-Directed Delivery of an AAV1 Vector Leads to Capsid-Specific T Cell Exhaustion in Nonhuman Primates and Humans |
| Q36406869 | Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy |
| Q37621530 | Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies |
| Q40282843 | Regulatory and Exhausted T Cell Responses to AAV Capsid. |
| Q38908933 | Systemic delivery of adeno-associated viral vectors |
| Q38539938 | The Skeletal Muscle Environment and Its Role in Immunity and Tolerance to AAV Vector-Mediated Gene Transfer |
| Q28543150 | Transgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primates |
| Q35664155 | Vectored antibody gene delivery for the prevention or treatment of HIV infection |
Search more.